C12N 2740/15044
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2740/15044 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 9
- Assignees
- 10
- Inventors
- 37
- Latest grant
- 4 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 0 | 1 |
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 0 | 2 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Mammalian cells and methods for engineering the same4 Mar 2025US 12,241,062 B264-X, Inc.
- Rev-dependent lentiviral vaccine particles for reducing viral rebound and viral reservoirs in vivo26 Dec 2023US 11,850,281 B2George Mason Research Foundation, Inc.
- Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof21 Jun 2022US 11,365,230 B2Immune Design Corp.
- Condition-controlled spliceable chimeric antigen receptor molecule and application thereof16 Oct 2025US 2025/0319126 A1Shanghai Sinobay Biotechnology Co., Ltd.
- Mammalian cells and methods for engineering the same7 Mar 2024US 2024/0076655 A164-X, Inc.
- Mammalian cells and methods for engineering the same15 Feb 2024US 2024/0052341 A164-X, Inc.
- Sirna expression vector24 Nov 2022US 2022/0372516 A1Takara Bio Inc.
- Viral targeting of hematopoietic stem cells27 Oct 2022US 2022/0340876 A1Massachusetts Institute of Technology
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.